Sanofi [SNY] moved up 0.60: Why It’s Important

- Advertisements -

Sanofi [NASDAQ: SNY] closed the trading session at $55.20 on 09/20/23. The day’s price range saw the stock hit a low of $55.10, while the highest price level was $55.72. The company report on September 19, 2023 at 2:30 AM that Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change.

Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change.

- Advertisements -

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The stocks have a year to date performance of 13.98 percent and weekly performance of 1.69 percent. The stock has been moved at 13.67 percent over the last six months. The stock has performed 2.77 percent around the most recent 30 days and changed 2.91 percent over the most recent 3-months.

If compared to the average trading volume of 1.23M shares, SNY reached to a volume of 2472350 in the most recent trading day, which is why market watchdogs consider the stock to be active.

- Advertisements -

Here’s what leading stock market gurus have to say about Sanofi [SNY]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SNY shares is $65.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SNY stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Berenberg have made an estimate for Sanofi shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 06, 2023.

The Average True Range (ATR) for Sanofi is set at 0.70, with the Price to Sales ratio for SNY stock in the period of the last 12 months amounting to 2.86. The Price to Book ratio for the last quarter was 1.79, with the Price to Cash per share for the same quarter was set at 3.34.

- Advertisements -

SNY stock trade performance evaluation

Sanofi [SNY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.69. With this latest performance, SNY shares gained by 2.77% in over the last four-week period, additionally plugging by 13.67% over the last 6 months – not to mention a rise of 35.99% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SNY stock in for the last two-week period is set at 62.57, with the RSI for the last a single of trading hit 66.92, and the three-weeks RSI is set at 59.52 for Sanofi [SNY]. The present Moving Average for the last 50 days of trading for this stock 53.38, while it was recorded at 54.65 for the last single week of trading, and 51.41 for the last 200 days.

Sanofi [SNY]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Sanofi [SNY] shares currently have an operating margin of +23.33 and a Gross Margin at +63.13. Sanofi’s Net Margin is presently recorded at +19.47.

Return on Total Capital for SNY is now 10.68, given the latest momentum, and Return on Invested Capital for the company is 9.34. Return on Equity for this stock inclined to 11.67, with Return on Assets sitting at 6.78. When it comes to the capital structure of this company, Sanofi [SNY] has a Total Debt to Total Equity ratio set at 28.36. Additionally, SNY Total Debt to Total Capital is recorded at 22.10, with Total Debt to Total Assets ending up at 16.74. Long-Term Debt to Equity for the company is recorded at 22.41, with the Long-Term Debt to Total Capital now at 17.46.

Reflecting on the efficiency of the workforce at the company, Sanofi [SNY] managed to generate an average of $91,413 per employee. Receivables Turnover for the company is 4.19 with a Total Asset Turnover recorded at a value of 0.35.Sanofi’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 1.20.

Earnings per share (EPS) analysis for Sanofi [SNY] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SNY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sanofi go to 6.97%.

Sanofi [SNY]: Institutional Ownership

The top three institutional holders of SNY stocks are: VANGUARD GROUP INC with ownership of 1.31 billion shares, which is approximately 8.2089%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $170.67 trillion in SNY stocks shares; and BERKSHIRE HATHAWAY INC, currently with $150.98 trillion in SNY stock with ownership which is approximately 5.7381%.

- Advertisements -

Leave a Reply

Your email address will not be published. Required fields are marked *